My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 101

    1.

    Mesenchymal stem cells avoid allogeneic rejection.

    Ryan JM, Barry FP, Murphy JM, Mahon BP.

    J Inflamm (Lond). 2005 Jul 26;2:8.PMID: 16045800 [PubMed]Related articlesFree article

    2.

    Immunogenicity of adult mesenchymal stem cells: lessons from the fetal allograft.

    Barry FP, Murphy JM, English K, Mahon BP.

    Stem Cells Dev. 2005 Jun;14(3):252-65. Review.PMID: 15969620 [PubMed - indexed for MEDLINE]Related articles

    3.

    Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

    Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L, Borg C, Saas P, Tiberghien P, Rouas-Freiss N, Carosella ED, Deschaseaux F.

    Stem Cells. 2008 Jan;26(1):212-22. Epub 2007 Oct 11.PMID: 17932417 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Characterization of a mesenchymal-like stem cell population from osteophyte tissue.

    Singh S, Jones BJ, Crawford R, Xiao Y.

    Stem Cells Dev. 2008 Apr;17(2):245-54.PMID: 18447640 [PubMed - indexed for MEDLINE]Related articles

    5.

    Adult mesenchymal stem cells for tissue engineering versus regenerative medicine.

    Caplan AI.

    J Cell Physiol. 2007 Nov;213(2):341-7. Review.PMID: 17620285 [PubMed - indexed for MEDLINE]Related articles

    6.

    Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells.

    English K, Ryan JM, Tobin L, Murphy MJ, Barry FP, Mahon BP.

    Clin Exp Immunol. 2009 Apr;156(1):149-60. Epub 2009 Feb 3.PMID: 19210524 [PubMed - indexed for MEDLINE]Related articles

    7.

    Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting.

    Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink EG, Willemze R, Fibbe WE.

    Blood. 2006 Sep 15;108(6):2114-20. Epub 2006 May 11.PMID: 16690970 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.

    Ishikane S, Ohnishi S, Yamahara K, Sada M, Harada K, Mishima K, Iwasaki K, Fujiwara M, Kitamura S, Nagaya N, Ikeda T.

    Stem Cells. 2008 Oct;26(10):2625-33. Epub 2008 Jul 31.PMID: 18669910 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Immunological properties of mesenchymal stem cells and clinical implications.

    Patel SA, Sherman L, Munoz J, Rameshwar P.

    Arch Immunol Ther Exp (Warsz). 2008 Jan-Feb;56(1):1-8. Epub 2008 Feb 5. Review.PMID: 18250975 [PubMed - indexed for MEDLINE]Related articles

    10.

    Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

    Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, Santarlasci V, Mazzinghi B, Pizzolo G, Vinante F, Romagnani P, Maggi E, Romagnani S, Annunziato F.

    Stem Cells. 2006 Feb;24(2):386-98. Epub 2005 Aug 25.PMID: 16123384 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Immunosuppression by placental indoleamine 2,3-dioxygenase: a role for mesenchymal stem cells.

    Jones BJ, Brooke G, Atkinson K, McTaggart SJ.

    Placenta. 2007 Nov-Dec;28(11-12):1174-81. Epub 2007 Aug 22.PMID: 17714779 [PubMed - indexed for MEDLINE]Related articles

    12.

    Adult mesenchymal stem cells: a pluripotent population with multiple applications.

    Porada CD, Zanjani ED, Almeida-Porad G.

    Curr Stem Cell Res Ther. 2006 Sep;1(3):365-9. Review.PMID: 18220880 [PubMed - indexed for MEDLINE]Related articles

    13.

    Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model.

    Inoue S, Popp FC, Koehl GE, Piso P, Schlitt HJ, Geissler EK, Dahlke MH.

    Transplantation. 2006 Jun 15;81(11):1589-95.PMID: 16770249 [PubMed - indexed for MEDLINE]Related articles

    15.

    Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate.

    Popp FC, Eggenhofer E, Renner P, Slowik P, Lang SA, Kaspar H, Geissler EK, Piso P, Schlitt HJ, Dahlke MH.

    Transpl Immunol. 2008 Nov;20(1-2):55-60. Epub 2008 Aug 30.PMID: 18762258 [PubMed - indexed for MEDLINE]Related articles

    16.

    Immunomodulation by mesenchymal stem cells and clinical experience.

    Le Blanc K, Ringdén O.

    J Intern Med. 2007 Nov;262(5):509-25. Review.PMID: 17949362 [PubMed - indexed for MEDLINE]Related articles

    17.

    Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation.

    Keyser KA, Beagles KE, Kiem HP.

    Cell Transplant. 2007;16(5):555-62.PMID: 17708345 [PubMed - indexed for MEDLINE]Related articles

    18.

    Mesenchymal stem cells for bone repair and metabolic bone diseases.

    Undale AH, Westendorf JJ, Yaszemski MJ, Khosla S.

    Mayo Clin Proc. 2009 Oct;84(10):893-902. Review.PMID: 19797778 [PubMed - indexed for MEDLINE]Related articles

    19.

    Brief report--human embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytes.

    Yen BL, Chang CJ, Liu KJ, Chen YC, Hu HI, Bai CH, Yen ML.

    Stem Cells. 2009 Feb;27(2):451-6.PMID: 18988708 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Adult mesenchymal stem cells in dental research: a new approach for tissue engineering.

    Trubiani O, Orsini G, Caputi S, Piatelli A.

    Int J Immunopathol Pharmacol. 2006 Jul-Sep;19(3):451-60. Review.PMID: 17026831 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk